HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

"Real-world data is no longer a concept, it's a capability," said Steve Kundrot, Chief Operating Officer at TriNetX. "The ...

Viagra, famously known for its use in treating erectile dysfunction medication, may have some unexpected health benefits.

Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public ...

Their findings suggest that this drug combination offers a novel strategy to help these patients control the disease in order to be eligible for stem cell transplants.

The Viewpoint addresses designations of novel drugs. The regulatory designation of new drugs is significant as it may confer exclusivity. The terminology for nonbiological drugs in the US is described ...

The Commissioner's National Priority Voucher program will shorten the FDA review time for selected drug application submissions from approximately 10 to 12 months to 1 to 2 months. HealthDay News — On ...